Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning. A lot of people had reactions, comments, and theories regarding Lizzy’s story yesterday on the mystery patient who received retatrutide. What’s undeniable, though, is the strength of Lizzy’s reporting.
